The U.S. Food and Drug Administration approved the first drug to treat cases of ovarian cancer linked to specific genetic mutations.
WSJ.com: US Business, Wall Street Journal: Business
Fri, 12/19/2014 - 3:12pm
The U.S. Food and Drug Administration approved the first drug to treat cases of ovarian cancer linked to specific genetic mutations.